ATS Announces GSK Grants to Support COVID-19 Crisis Fund’s Research and Outreach Efforts
American Thoracic Society (ATS)Today, the American Thoracic Society announced that GlaxoSmithKline (GSK) has awarded the Society two grants totaling $380,000 to support the ATS COVID-19 Crisis Fund, a newly launched initiative to develop and disseminate research, education and scientific recommendations to providers in the pulmonary and critical care communities, as well as other clinicians in need of expanding their skill set during this emergency. The first grant will fund two new $50,000 grants in the ATS Research Program in COVID-19. The second grant for $280,000 will support the Society’s patient education and outreach efforts related to COVID-19.